ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $492,000 | -7.7% | 39,602 | +1.9% | 0.01% | -12.5% |
| Q3 2016 | $533,000 | +85.7% | 38,875 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $287,000 | +0.7% | 38,875 | -12.9% | 0.01% | 0.0% |
| Q1 2016 | $285,000 | -5.6% | 44,625 | -7.8% | 0.01% | -16.7% |
| Q4 2015 | $302,000 | +16.2% | 48,403 | +8.8% | 0.01% | +20.0% |
| Q3 2015 | $260,000 | -33.0% | 44,486 | -5.2% | 0.01% | -28.6% |
| Q2 2015 | $388,000 | +2.6% | 46,908 | +2.4% | 0.01% | 0.0% |
| Q1 2015 | $378,000 | +16.7% | 45,808 | -2.7% | 0.01% | 0.0% |
| Q4 2014 | $324,000 | +32.2% | 47,058 | +3.7% | 0.01% | 0.0% |
| Q3 2014 | $245,000 | +142.6% | 45,358 | +186.3% | 0.01% | +133.3% |
| Q2 2014 | $101,000 | -65.1% | 15,842 | -55.9% | 0.00% | -62.5% |
| Q1 2014 | $289,000 | +26.2% | 35,889 | +6.8% | 0.01% | +14.3% |
| Q4 2013 | $229,000 | +27.9% | 33,592 | +245.3% | 0.01% | +16.7% |
| Q3 2013 | $179,000 | +4.7% | 9,727 | -0.2% | 0.01% | 0.0% |
| Q2 2013 | $171,000 | – | 9,747 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |